160 related articles for article (PubMed ID: 779631)
1. Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.
Beggs WH; Sarosi GA; Steele NM
Antimicrob Agents Chemother; 1976 Jun; 9(6):863-5. PubMed ID: 779631
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
Hoeprich PD; Huston AC
J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
[TBL] [Abstract][Full Text] [Related]
3. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
Beggs WH; Andrews FA; Sarosi GA
Chemotherapy; 1981; 27(4):247-51. PubMed ID: 7195793
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
Beggs WH; Sarosi GA
Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
[TBL] [Abstract][Full Text] [Related]
5. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Chen HH; Liushih RN; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
[TBL] [Abstract][Full Text] [Related]
6. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
Guinet R
Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
[TBL] [Abstract][Full Text] [Related]
7. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
Rumler W; Heins S
Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
[No Abstract] [Full Text] [Related]
8. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
Shadomy S; Wagner G; Espinel-Ingroff E; Davis BA
Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
[TBL] [Abstract][Full Text] [Related]
9. Synergism of amphotericin B and 5-fluorocytosine for candida species.
Montgomerie JZ; Edwards JE; Guze LB
J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
[TBL] [Abstract][Full Text] [Related]
10. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Odds FC
Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
[TBL] [Abstract][Full Text] [Related]
11. Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation.
Alvarez C; Andes DR; Kang JY; Krug C; Kwon GS
Pharm Res; 2017 May; 34(5):1115-1124. PubMed ID: 28205003
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
Nobre G; Sobral T; Ferreira AF
Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
[TBL] [Abstract][Full Text] [Related]
13. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
Ellis NS; Bartlett MS; Smith JW
Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
[TBL] [Abstract][Full Text] [Related]
14. Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles.
Vakil R; Knilans K; Andes D; Kwon GS
Pharm Res; 2008 Sep; 25(9):2056-64. PubMed ID: 18415047
[TBL] [Abstract][Full Text] [Related]
15. [Effect of synthetic antifungal drugs on the adherence of Candida albicans to the mouth mucosa epithelium in vitro].
Macura AB; Dwernicka B
Med Dosw Mikrobiol; 1989; 41(1):67-70. PubMed ID: 2668662
[TBL] [Abstract][Full Text] [Related]
16. Interaction between Candida agglutinins and antifungal agents.
Lutz JC; Nugent KM
Mycopathologia; 1987 Jul; 99(1):21-4. PubMed ID: 3306393
[TBL] [Abstract][Full Text] [Related]
17. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
Hamilton-Miller JM
Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
[No Abstract] [Full Text] [Related]
18. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
Hamra LK; Pankiewicz IJ
Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
[TBL] [Abstract][Full Text] [Related]
19. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
Mínguez Mínguez F; Lima JE; García MT; Prieto J
Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
[TBL] [Abstract][Full Text] [Related]
20. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
